Stability of FR264205 against AmpC β-lactamase of Pseudomonas aeruginosa

International Journal of Antimicrobial Agents

Volumn 30, Issue 5, 2007, Pages 443-445

  Takeda, Shinobu ^a   Ishii, Yoshikazu ^b   Hatano, Kazuo ^a   Tateda, Kazuhiro ^b   Yamaguchi, Keizo ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AmpC lactamase; FR264205; Pseudomonas aeruginosa

Indexed keywords

BETA LACTAMASE AMPC; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; FR 264205; NITROCEFIN; UNCLASSIFIED DRUG;

ARTICLE; DELFTIA ACIDOVORANS; DRUG HYDROLYSIS; DRUG STABILITY; DRUG STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BACTERIAL PROTEINS; BETA-LACTAMASES; CEFTAZIDIME; CEPHALOSPORINS; GENE DELETION; MICROBIAL SENSITIVITY TESTS; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; PSEUDOMONAS AERUGINOSA;

EID: 34848844055     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.05.019     Document Type: Article

References (13)

1. de Champs C., Poirel L., Bonnet R., et al. Prospective survey of β-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolated in a French hospital in 2000. Antimicrob Agents Chemother 46 (2002) 3031-3034
2. Takeda S., Nakai T., Wakai Y., Ikeda F., and Hatano K. In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa. Antimicrob Agents Chemother 51 (2007) 826-830
3. Juan C., Moya B., Perez J.L., and Oliver A. Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level β-lactam resistance involves three AmpD homologues. Antimicrob Agents Chemother 50 (2006) 1780-1787
4. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7. Wayne, PA: CLSI; 2006.
5. Prentki P., Binda A., and Epstein A. Plasmid vectors for selecting IS1-promoted deletions in cloned DNA: sequence analysis of the omega interposon. Gene 103 (1991) 17-23
6. Tsuda M. Use of a transposon-encoded site-specific resolution system for construction of large and defined deletion mutations in bacterial chromosome. Gene 207 (1998) 33-41
7. Tsuda M., Miyazaki H., and Nakazawa T. Genetic and physical mapping of genes involved in pyoverdin production in Pseudomonas aeruginosa PAO. J Bacteriol 177 (1995) 423-431
8. Simon R., Priefer U., and Pühler A. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram-negative bacteria. Biotechnology 1 (1983) 784-790
9. Ishii Y., Ohno A., Taguchi H., Imajo S., Ishiguro M., and Matsuzawa H. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A β-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 39 (1995) 2269-2275
10. Alba J., Bauvois C., Ishii Y., et al. A detailed kinetic study of Mox-1, a plasmid-encoded class C β-lactamase. FEMS Microbiol Lett 225 (2003) 183-188
11. Cartwright S.J., and Waley S.G. Purification of β-lactamases by affinity chromatography on phenylboronic acid-agarose. Biochem J 221 (1984) 505-512
12. Juan C., Macia M.D., Gutierrez O., Vidal C., Perez J.L., and Oliver A. Molecular mechanisms of β-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains. Antimicrob Agents Chemother 49 (2005) 4733-4738
13. Langaee T.Y., Gagnon L., and Huletsky A. Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC β-lactamase expression. Antimicrob Agents Chemother 44 (2000) 583-589